APA

Simpson E. L., Lacour J., Spelman L., Galimberti R., Eichenfield L. F., Bissonnette R., King B. A., Thyssen J. P., Silverberg J. I., Bieber T., Kabashima K., Tsunemi Y., Costanzo A., Guttman-Yassky E., Beck L. A., Janes J. M., DeLozier A. M., Gamalo M., Brinker D. R., Cardillo T., Nunes F. P., Paller A. S., Wollenberg A. & Reich K. (20210514). Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. : The British journal of dermatology.

Chicago

Simpson E L, Lacour J-P, Spelman L, Galimberti R, Eichenfield L F, Bissonnette R, King B A, Thyssen J P, Silverberg J I, Bieber T, Kabashima K, Tsunemi Y, Costanzo A, Guttman-Yassky E, Beck L A, Janes J M, DeLozier A M, Gamalo M, Brinker D R, Cardillo T, Nunes F P, Paller A S, Wollenberg A and Reich K. 20210514. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. : The British journal of dermatology.

Harvard

Simpson E. L., Lacour J., Spelman L., Galimberti R., Eichenfield L. F., Bissonnette R., King B. A., Thyssen J. P., Silverberg J. I., Bieber T., Kabashima K., Tsunemi Y., Costanzo A., Guttman-Yassky E., Beck L. A., Janes J. M., DeLozier A. M., Gamalo M., Brinker D. R., Cardillo T., Nunes F. P., Paller A. S., Wollenberg A. and Reich K. (20210514). Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. : The British journal of dermatology.

MLA

Simpson E L, Lacour J-P, Spelman L, Galimberti R, Eichenfield L F, Bissonnette R, King B A, Thyssen J P, Silverberg J I, Bieber T, Kabashima K, Tsunemi Y, Costanzo A, Guttman-Yassky E, Beck L A, Janes J M, DeLozier A M, Gamalo M, Brinker D R, Cardillo T, Nunes F P, Paller A S, Wollenberg A and Reich K. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. : The British journal of dermatology. 20210514.